Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
CASI Pharmaceuticals Inc. (CASI) had Current Assets of $11.91M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$3.08M |
|
$-10.88M |
|
$2.37M |
|
$0.71M |
|
$13.75M |
|
$-10.68M |
|
$-0.21M |
|
$-10.88M |
|
$-10.88M |
|
$-10.88M |
|
$-10.88M |
|
$-10.88M |
|
$-10.88M |
|
$-10.68M |
|
$-10.68M |
|
16.05M |
|
16.05M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
|
Current Assets |
$11.91M |
$7.14M |
|
$12.55M |
|
$24.46M |
|
$39.42M |
|
-- |
|
$13.63M |
|
$53.05M |
|
$-28.59M |
|
$-28.82M |
|
$-28.59M |
|
20.55M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.30 |
|
-- |
|
-- |
|
-- |
|
-0.66 |
|
22.96% |
|
-347.22% |
|
-347.22% |
|
-- |
|
-353.92% |
|
-353.92% |
|
-- |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.91 |
|
1.18 |
|
76.36 |
|
38.06% |
|
37.77% |
|
-44.49% |
|
38.06% |
|
$-1.39 |
|
-- |
|
-- |
|